A Florida woman has gained viral attention after sharing the clever way she stopped her expensive spray tan bottle from being ...

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

Live your life healthier and happier with our free weekly Living Well newsletter Every minute, one million plastic bottles are bought around the world. And of the single-use plastic food and drink ...

The plot has thickened in the Justin Trudeau-Heinz ketchup controversy, as consumers with bottles that say "Product of USA" question how Canadian the popular condiment really is. Kraft Heinz took ...

As part of a novel initiative to combat plastic waste, UK households will be rewarded for returning empty bottles to their local supermarkets. This deposit return scheme, already implemented in ...

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

After years of lugging around wide-mouth insulated bottles (and not-so-gracefully chugging them at the gym), the brand’s proprietary hidden straw truly spoke to me. If you’ve ever tried ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Mystery surrounds a 200-year-old bottle of urine found on a Cleethorpes building site. It was discovered by workers who were digging trenches at a property in Sea View Street last year.

ABC Science took three packaging products that are common and relatively easy to recycle — glass bottles, aluminium cans and PET plastic bottles — to see just how much of each makes it through ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...